This lab doesn't publish a public lookup, so we can't confirm the certificate against the lab's own record. The document was reviewed before publication, but it rests on our review alone.
What portal verification means →This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 40 mg · Lab measured 42.86 mg
107% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 10.7 mg using the measured mass, against 10 mg on the label — 7% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | TUY-011526 |
|---|---|
| Portal lookup | Lab has no portalThis laboratory publishes no public lookup, so the report cannot be confirmed independently. |
| PDF vs portal | Ethos Analytics's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of MOTS-C from purehealthpeptides.com, performed by Ethos Analytics on February 2, 2026. Reported purity: 99%. Net content: 42.86 mg against 40 mg labeled (107% of label). Batch TUY-011526. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| TUY-030926 | 6 May 2026 | Ethos Analytics | 99% | 105% | Lab has no portal |
| CHA-011926 | 11 Feb 2026 | Bioviridian | 99.8% | 103% | Unverified |
| RPL-011526 | 4 Feb 2026 | Bioviridian | 99.8% | 103% | Unverified |
| TUY-011526 | 4 Feb 2026 | Bioviridian | 99.8% | 99% | Unverified |
| RPL-010826 | 22 Jan 2026 | Ethos Analytics | 99% | 104% | Lab has no portal |
| TUY-101025 | 7 Nov 2025 | BioRegen | 99.97% | 102% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion